Fosun to buy 74% stake in Gland Pharma

Views: 1.0K

FosunShanghai Fosun Pharmaceutical Group Co. Ltd, a unit of China’s Fosun Group has agreed to acquire 74 percent  of Indian drug company Gland Pharma Ltd for $1.1 billion.

Fosun Pharma had struck a deal in July last year to buy an 86 percent stake valued at about $1.26 billion in the Indian generic injectable drugmaker.

However, according to reports, the deal was put in cold storage by the Government of India.  Foreign investment of up to 100 percent in Indian pharmaceutical sector is allowed, but above 74 percent requires government approval. Moreover, Gland Pharma’s founding members reportedly wanted to retain a bigger holding in their company.

Reviving the deal, Fosun has agreed to cut the size of the stake it will buy in Gland Pharma to 74%.

In a statement to the stock exchanges, the company said  that its board had approved the new plan to acquire 74%, which would see an investment of up to $1.09 billion.

Most Popular





Get Heard Portal


eHealth Event Report




About Us

eHEALTH, as an online and print platform, elegantly guides the healthcare stakeholders through the trajectory of healthcare that witnesses fascinating changes on a daily basis due to increased technological intervention and other structural changes to create a ‘community of practice’ of healthcare stakeholders.


Contact Us

Elets Technomedia Pvt. Ltd.
Stellar IT Park, Office No. 7A/7B, 5th Floor, Tower -2 Annexe Building, C-25, Sector 62 Noida, Uttar Pradesh - 201309, India

Copyright © 2018 Elets | All rights reserved

To Top